Acorah Software Products - Accounts Production16.3.350truetruefalsetrueNo description of principal activity15 January 202431 January 202531 January 202515412810Mr Mehtab HussainMr Elugba Wanoghoiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure154128102024-01-14154128102025-01-31154128102024-01-152025-01-3115412810frs-bus:PrivateLimitedCompanyLtd2024-01-152025-01-3115412810frs-bus:FilletedAccounts2024-01-152025-01-3115412810frs-bus:Micro-entities2024-01-152025-01-3115412810frs-bus:EntityHasNeverTraded2024-01-152025-01-3115412810frs-bus:AuditExempt-NoAccountantsReport2024-01-152025-01-3115412810frs-bus:Director12024-01-152025-01-3115412810frs-bus:Director22024-01-152025-01-31
Registered number: 15412810
Emie Pharmaceuticals ( UK ) Ltd
Unaudited Dormant Financial Statements
For the Period 15 January 2024 to 31 January 2025
Emie Pharmaceuticals ( UK ) Ltd
Balance Sheet
As At 31 January 2025
Balance Sheet
Registered number: 15412810
31 January 2025
£
Current assets
100
NET CURRENT ASSETS
100
TOTAL ASSETS LESS CURRENT LIABILITIES
100
NET ASSETS
100
CAPITAL AND RESERVES
100
Notes
1.General Information
Emie Pharmaceuticals ( UK ) Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15412810. The registered office is 31 Jacmar Crescent, Smethwick, West Midlands, B67 7LE.
2.Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
Page 0
Page 1
Emie Pharmaceuticals ( UK ) Ltd
Balance Sheet (continued)
As At 31 January 2025
For the period ending 31 January 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.